| mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
5e-08 |
| mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.19 |
6e-08 |
| mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
7e-08 |
| mRNA |
XMD13-2 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
1e-07 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
2e-07 |
| mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-07 |
| mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
3e-07 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-07 |
| mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-07 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-07 |